A surrogate lipid marker for atherosclerotic risk. LDL-C lowering is associated with reduced cardiovascular events, but ApoB may add prognostic value when discordant with LDL-C.
A surrogate lipid marker for atherosclerotic risk. LDL-C lowering is associated with reduced cardiovascular events, but ApoB may add prognostic value when discordant with LDL-C.